Genital WartsThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.

• By Date
• Specialty Filter
• Discussions
• Top 20

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  

Rapid decline in presentations of genital warts after the implementation of a national quadrivalent human papillomavirus vaccination programme for young womenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: The data suggest that a rapid and marked reduction in the incidence of genital warts among vaccinated women may be achievable through an HPV vaccination programme targeting women, and supports some benefit being conferred to heterosexual men. (Source: Sexually Transmitted Infections)
Source: Sexually Transmitted Infections - November 20, 2009 Category: Sexual Medicine Authors: Fairley, C K, Hocking, J S, Gurrin, L C, Chen, M Y, Donovan, B, Bradshaw, C S Tags: Vaccination programs, Drugs: infectious diseases, Vaccination / immunisation, Dermatology, Other viral STIs Epidemiology Source Type: journals

Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in ThailandEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: One-third of HIV positive and 12.5% of HIV negative MSM had ASIL. Thus, as greater numbers of HIV positive MSM live longer due to increasing access to HAART worldwide, effective strategies to screen and manage anal precancerous lesions are needed. (Source: Sexually Transmitted Infections)
Source: Sexually Transmitted Infections - November 20, 2009 Category: Sexual Medicine Authors: Li, A H, Phanuphak, N, Sahasrabuddhe, V V, Chaithongwongwatthana, S, Vermund, S H, Jenkins, C A, Shepherd, B E, Teeratakulpisarn, N, van der Lugt, J, Avihingsanon, A, Ruxrungtham, K, Shikuma, C, Phanuphak, P, Ananworanich, J Tags: Drugs: infectious diseases, HIV/AIDS, Cervical cancer, Cervical screening, Gynecological cancer, HIV / AIDS, HIV infections, Vulvovaginal disorders Clinical Source Type: journals

The psychosocial burden of human papillomavirus related disease and screening interventionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: Clinicians need to be aware of the potential psychosocial impact of testing for or diagnosing HPV-related genital disease, in particular CIN 2/3 and EGW. The HIP survey is a more sensitive measure of the psychosocial impact of HPV-related genital disease than generic QoL surveys. (Source: Sexually Transmitted Infections)
Source: Sexually Transmitted Infections - November 20, 2009 Category: Sexual Medicine Authors: Pirotta, M, Ung, L, Stein, A, Conway, E L, Mast, T C, Fairley, C K, Garland, S Tags: Cervical cancer, Cervical screening, Gynecological cancer, Screening (oncology), Dermatology, Other viral STIs, Vulvovaginal disorders, Surgical diagnostic tests, Clinical diagnostic tests, Screening (epidemiology), Screening (public health) Source Type: journals

Isolated necrotizing granulomatous vasculitis of the uterine cervix associated with human papillomavirus infectionEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We report a case of isolated necrotizing granulomatous vasculitis of the uterine cervix in a middle-aged woman, previously healthy, and sexually active, and whose human papillomavirus (HPV) DNA hybrid capture assay was positive. Systemic involvement was not detected and, since the lesion was completely removed, we opted for a clinical follow-up. The literature has very few reports on the isolated involvement of the female genital tract, and some had concomitant lesions that could be caused by the HPV, indicati. (Source: Revista Brasileira de Reumatologia)
Source: Revista Brasileira de Reumatologia - November 20, 2009 Category: Rheumatology Source Type: journals

Guidelines Push Back Age for Cervical Cancer TestsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
New guidelines for cervical cancer screening say women should delay their first Pap test until age 21, and go for screening less often than had been previously recommended. (Source: NYT > Health)
Source: NYT > Health - November 20, 2009 Category: Consumer Health News Authors: By DENISE GRADY Tags: Tests and Testing Human Papilloma Virus (HPV) Cervix Cancer American College of Obstetricians and Gynecologists Source Type: news

Co-Expression of p53 and Bcl-2 Proteins in Human Papillomavirus-Induced Premalignant Lesions of the Uterine Cervix: Correlation with Progression to MalignancyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Tumor Biol 2009;30:276-285 (DOI:10.1159/000259911) (Source: Karger Publishers)
Source: Karger Publishers - November 19, 2009 Category: Cancer & Oncology Source Type: journals

CDC Lifts HPV Vaccination Requirement For Young Female ImmigrantsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Starting Dec. 14, the U.S. will no longer require female immigrants seeking permanent resident status to be vaccinated against the human papillomavirus, the Centers for Disease Control and Prevention announced on Friday, the AP/San Francisco Chronicle reports. The new rule revises July 2008 guidelines that required female immigrants ages 11 through 26 seeking legal U.S. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Circumcision and Risk of Sexually Transmissible Infections in a Community-Based Cohort of HIV-Negative Homosexual Men in Sydney, Australia.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions. These are the first prospective data obtained from homosexual men to assess circumcision status as a risk factor for STIs. Circumcised men were at reduced risk of incident syphilis but no other prevalent or incident STIs. Circumcision is unlikely to have a substantial public health impact in reducing acquisition of most STIs in homosexual men. PMID: 19911990 [PubMed - as supplied by publisher] (Source: Herpes)
Source: Herpes - November 19, 2009 Category: Infectious Diseases Authors: Templeton DJ, Jin F, Prestage GP, Donovan B, Imrie JC, Kippax SC, Cunningham PH, Kaldor JM, Mindel A, Cunningham AL, Grulich AE Tags: J Infect Dis Source Type: journals

Introduction of human papillomavirus (HPV) vaccination in Belgium, 2007-2008Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
This paper documents the progress of human papillomavirus (HPV) vaccine introduction in Belgium. Information on vaccine use is based on sales statistics and reimbursement claims. From November 2007 to November 2008, the National Institute for Health and Disability Insurance reimbursed the HPV vaccine for girls aged between 12-15 years. In December 2008, the age limit was extended to include girls up to the age of 18. In November 2008, the total number of HPV vaccines sold exceeded 530,000 doses. The number of vaccines reimbursed in Belgium, for the period November 2007-November 2008, corresponds to the amount required to f...
Source: Eurosurveillance latest news - November 19, 2009 Category: Infectious Diseases Source Type: journals

Self-reported sexual debut and behavior in young adults aged 18-24 years in seven European countries: implications for HPV vaccination programs.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: This survey provides an update on sexual debut and behavior in young adults in some European countries. Estimated age at sexual debut ranged between 16 and 18 years and appeared to be later in girls than in boys. The proportion of girls sexually active before the age of 15 years was low (</=11.9%). Almost one-third of young women did not use a condom. This survey provides useful information to support current or planned HPV vaccination programs in Europe. PMID: 19552945 [PubMed - in process] (Source: Gynecologic Oncology)
Source: Gynecologic Oncology - November 18, 2009 Category: Cancer & Oncology Authors: Crochard A, Luyts D, di Nicola S, Gonçalves MA Tags: Gynecol Oncol Source Type: journals

Ethnic differences in human papillomavirus awareness and vaccine acceptabilityEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion: These findings suggest some cultural barriers that could be addressed in tailored information aimed at ethnic minority groups. They also highlight the importance of recording ethnicity as part of HPV vaccine uptake data. (Source: Journal of Epidemiology and Community Health)
Source: Journal of Epidemiology and Community Health - November 18, 2009 Category: Epidemiology Authors: Marlow, L A V, Wardle, J, Forster, A S, Waller, J Tags: Epidemiologic studies, Cross-sectional studies, Ethnic studies Research reports Source Type: journals

Blogs Comment On Abortion Issues In Health Reform, HPV Vaccinations For ImmigrantsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The following summarizes selected women's health-related blog entries. ~ "DeGette: Stupak Agenda Is Much Wider Restrictions on Abortion," Brian Beutler, Talking Points Memo: Rep. Diana DeGette (D-Colo.) "takes issue" with Rep. Bart Stupak's (D-Mich.) "interpretation of the events leading up to the vote that completely changed the stakes of reform debate," Beutler writes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 18, 2009 Category: Consumer Health News Tags: Abortion Source Type: news

Prevention and treatment of cervical cancer in mice using estrogen receptor antagonists [Medical_Sciences]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The majority of human cervical cancers are associated with the high-risk human papillomavirus (HPV) types. In mouse models for HPV-associated... (Source: Proceedings of the National Academy of Sciences)
Source: Proceedings of the National Academy of Sciences - November 17, 2009 Category: Science Authors: Chung, S.-H., Lambert, P. F. Tags: Medical_Sciences Source Type: journals

Less Than Half of College Women Vaccinated Against HPVEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new study shows that only 41% of young women in college are vaccinated against human papillomavi-rus; 30% of unvaccinated women believe the vaccine will "make them sick." Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 17, 2009 Category: Consumer Health News Tags: Public Health & Prevention Source Type: news

Green Card Seekers Won't Need HPV VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: WDSU.com - Health)
Source: WDSU.com - Health - November 17, 2009 Category: Consumer Health News Authors: WDSU.com Source Type: news

National Briefing | Immigration: Vaccine Requirement to Be EndedEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: NYT)
Source: NYT - November 17, 2009 Category: American Health Authors: By THE ASSOCIATED PRESS Tags: Vaccination and Immunization Human Papilloma Virus (HPV) Immigration and Emigration Centers for Disease Control and Prevention Women and Girls Source Type: news

Novel human papillomavirus type 18 replicon and its application in screening the antiviral effects of cytokinesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In this report, we developed a new system for the analysis of the HPV lifecycle. The new system consists of a novel HPV replicon and an organotypic "raft" culture, by which the HPV-DNA is maintained stably in normal human keratinocytes for a long period and the viral vegetative replication is reproduced. This system will benefit biochemical and genetic studies on the lifecycle of HPV and tumorigenesis. This system is also valuable in screening for antiviral compounds. We confirmed its usefulness by evaluating the antivirus effect of cytokines. (Cancer Sci 2009 00: 000[ndash]000) (Source: Cancer Science)
Source: Cancer Science - November 17, 2009 Category: Cancer & Oncology Authors: Ayano Satsuka, Satoshi Yoshida, Naoko Kajitani, Hiroyasu Nakamura, Hiroyuki Sakai Source Type: journals

Immigrant seekers won't have to get HPV vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their permanent U.S. ... (Source: USATODAY.com Health)
Source: USATODAY.com Health - November 16, 2009 Category: Consumer Health News Source Type: news

Green Card Seekers Won't Have To Get HPV VaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Immigrant girls and women will no longer have to be vaccinated against a sexually transmitted virus to get their green cards. (Source: WDSU.com - Health)
Source: WDSU.com - Health - November 16, 2009 Category: Consumer Health News Authors: WDSU.com Source Type: news

Predicting Residual Neck Disease in Patients With Oropharyngeal Squamous Cell Carcinoma Treated With Radiation Therapy: Utility of p16 Status [Original Article]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions  In conjunction with other clinical parameters, p16 status can help predict the need for post-RT ND in patients with OP-SCCA. Although close observation may be warranted in selected patients with p16+ tumors, patients with p16– tumors are at much higher risk for residual neck disease, even when initial nodal disease is less advanced. (Source: Archives of Otolaryngology)
Source: Archives of Otolaryngology - November 16, 2009 Category: ENT & OMF Authors: Shonka, D. C., Shoushtari, A. N., Thomas, C. Y., Moskaluk, C., Read, P. W., Reibel, J. F., Levine, P. A., Jameson, M. J. Tags: Oncology, Head & Neck Cancer, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiation Therapy, Papillomavirus, Human, Prognosis/ Outcomes Original Article Source Type: journals

Immune Response During Therapy With Cisplatin or Radiation for Human Papillomavirus-Related Head and Neck Cancer [Original Article]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions  The HPV-positive tumors are not more curable based on increased epithelial sensitivity to cisplatin or radiation therapy. Instead, radiation and cisplatin induce an immune response to this antigenic cancer. The implications of these results may lead to novel therapies that enhance tumor eradication for HPV-positive cancers. (Source: Archives of Otolaryngology)
Source: Archives of Otolaryngology - November 16, 2009 Category: ENT & OMF Authors: Spanos, W. C., Nowicki, P., Lee, D. W., Hoover, A., Hostager, B., Gupta, A., Anderson, M. E., Lee, J. H. Tags: Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Radiation Therapy, Drug Therapy, Drug Therapy, Other, Immunology, Immunology, Other Original Article Source Type: journals

A 25-Year Analysis of Veterans Treated for Tonsillar Squamous Cell Carcinoma [Original Article]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion  In veterans treated for tonsillar SCC, we advocate the consideration of a treatment plan that includes surgery for patients presenting with advanced-stage SCC of the tonsil, even in patients with notable comorbidities. (Source: Archives of Otolaryngology)
Source: Archives of Otolaryngology - November 16, 2009 Category: ENT & OMF Authors: Jaber, J. J., Moreira, J., Canar, W. J., Bier-Laning, C. M. Tags: Oncology, Head & Neck Cancer, Oncology, Other, Otolaryngology/ Head & Neck Surgery, Neoplasms of Head & Neck, Public Health, Tobacco, Radiation Therapy, Surgery, Surgical Interventions, Surgical Oncology, Prognosis/ Outcomes Original Article Source Type: journals

FDA approves cervical cancer vaccineEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Cervarix has won FDA approval for the prevention of cervical pre-cancers and cervical cancer associated with HPV-16 and HPV-18 for use in girls and young women (ages 10-25), according to GlaxoSmithKline. In clinical trials, the vaccine was shown to be 93% effective in the prevention of cervical pre-cancers associated with HPV -16 or 18, in women without evidence of current infection with, or prior exposure to, the same HPV type at the time of vaccination. (Source: Cancer Network)
Source: Cancer Network - November 16, 2009 Category: Cancer & Oncology Source Type: info

HPV Viral Activity By mRNA-HPV Molecular Analysis To Screen The Transforming Infections In Precancer Cervical Lesions.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion: the contemporary utilization of E6-E7 oncoproteins and related mRNA expression showed a more appropriate HPV evaluation in at risk women. The HPV-DNA tests does not distinguish between transient and potentially transforming infection, while the detection of E6-E7 mRNAs could early target the presence of an active HPV infection. PMID: 19912106 [PubMed - as supplied by publisher] (Source: Current Pharmaceutical Biotechnology)
Source: Current Pharmaceutical Biotechnology - November 16, 2009 Category: Biotechnology Authors: Tinelli A, Leo G, Pisanò M, Storelli F, Vergara D, Malvasi A Tags: Curr Pharm Biotechnol Source Type: journals

Centers For Medicare & Medicaid Services Approves FDG PET For Cervical Cancer StagingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SNM applauds the Centers for Medicare & Medicaid Services' (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions. "CMS' decision to expand coverage of FDG PET for the initial treatment strategy evaluation of cervical cancer is important for patient care," said Michael M. Graham, Ph.D., M.D., president of SNM. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 14, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Centers For Medicare & Medicaid Services Approves FDG PET For Cervical Cancer StagingEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
SNM applauds the Centers for Medicare & Medicaid Services' (CMS) decision to expand coverage of FDG PET for the initial staging of cervical cancer without previously imposed restrictions. "CMS' decision to expand coverage of FDG PET for the initial treatment strategy evaluation of cervical cancer is important for patient care," said Michael M. Graham, Ph.D., M.D., president of SNM. (Source: MRI / PET / Ultrasound News From Medical News Today)
Source: MRI / PET / Ultrasound News From Medical News Today - November 14, 2009 Category: Radiology Tags: Cervical Cancer / HPV Vaccine Source Type: news

Circumcision and Risk of Sexually Transmissible Infections in a Community‐Based Cohort of HIV‐Negative Homosexual Men in Sydney, AustraliaEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions. These are the first prospective data obtained from homosexual men to assess circumcision status as a risk factor for STIs. Circumcised men were at reduced risk of incident syphilis but no other prevalent or incident STIs. Circumcision is unlikely to have a substantial public health impact in reducing acquisition of most STIs in homosexual men. (Source: The Journal of Infectious Diseases Latest Issue)
Source: The Journal of Infectious Diseases Latest Issue - November 13, 2009 Category: Infectious Diseases Tags: article MAJOR ARTICLE Source Type: journals

HPV vaccine proposed for teen boysEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Some doctors are concerned that the qualified recommendation from a CDC advisory panel could create insurance coverage problems. (Source: American Medical News - PROFESSION)
Source: American Medical News - PROFESSION - November 13, 2009 Category: American Health Source Type: news

Disease Progression And Survival Of Cervical Cancer Patients: Genetic Changes Are Important IndicatorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study by Norwegian researchers published November 13 in the open-access journal PLoS Genetics reports that cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 13, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Disease Progression And Survival Of Cervical Cancer Patients: Genetic Changes Are Important IndicatorsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A study by Norwegian researchers published November 13 in the open-access journal PLoS Genetics reports that cervical cancer patients with specific changes in the cancer genome have a three- or fourfold increased risk of relapse after standard treatment compared to patients without these changes. Research suggests that specific genetic changes are critical steps in the progression of the disease towards an aggressive and treatment-resistant state. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 13, 2009 Category: Cancer & Oncology Tags: Cervical Cancer / HPV Vaccine Source Type: news

Epigenetic Silencing of Interferon-{kappa} in Human Papillomavirus Type 16-Positive CellsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
We have investigated interferon- (IFN-) regulation in the context of human papillomavirus (HPV)–induced carcinogenesis using primary human foreskin keratinocytes (HFK), immortalized HFKs encoding individual oncoproteins of HPV16 (E6, E7, and E6/E7), and cervical carcinoma cells. Here, IFN- was suppressed in the presence of E6, whereas its expression was not affected in HFKs or E7-immortalized HFKs. Transcription could be reactivated after DNA demethylation but was decreased again upon drug removal. Partial reactivation could also be accomplished when E6 was knocked down, suggesting a contribution of E6 in IFN- de nov...
Source: Cancer Research - November 12, 2009 Category: Cancer & Oncology Authors: Rincon-Orozco, B., Halec, G., Rosenberger, S., Muschik, D., Nindl, I., Bachmann, A., Ritter, T. M., Dondog, B., Ly, R., Bosch, F. X., Zawatzky, R., Rosl, F. Tags: Molecular Biology, Pathobiology, and Genetics Source Type: journals

CERVARIX (Human Papillomavirus Bivalent (Types 16 And 18) Vaccine, Recombinant) Injection, Suspension [GlaxoSmithKline Biologicals SA]Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Updated Date: Nov 12, 2009 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST))
Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST) - November 12, 2009 Category: Drugs & Pharmacology Source Type: organizations

Poor value chlamydia screening programmeEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
National Audit Office says £17m in savings could have been madeRelated items from OnMedicaCervical cancer vaccine choice criticisedMiddle-aged women may benefit from HPV vaccine Third of schools offer sex education clinicsGP incentives not always best for improving healthy lifestyleOver 45s take risks with their sexual health (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 12, 2009 Category: UK Health Source Type: news

Immunosuppressive cytokine Interleukin-10 (IL-10) is up-regulated in high-grade CIN but not associated with high-risk human papillomavirus (HPV) at baseline, outcomes of HR-HPV infections or incident CIN in the LAMS cohortEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Abstract  Bypassing the local immunological defense reactions in the cervix is one of the prerequisites for human papillomaviruses (HPV) infections to progress to intraepithelial neoplasia (CIN). The role of potent immunosuppressive cytokines, e.g., interleukin-10 (IL-10), depressing these local virus-specific immunological responses is incompletely studied. To assess, whether IL-10 expression in cervical HPV lesions has any implications in the outcome of HPV infections or disease progression to CIN. Baseline cervical biopsies from 225 women of the LAMS study sub-cohort were analyzed for IL-10 expression usin...
Source: Virchows Archiv - November 11, 2009 Category: Pathology Tags: Virchows Archiv Source Type: journals

Human papillomavirus vaccine recombinant quadrivalent: Various toxicities: 8 case reportsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Source: Reactions)
Source: Reactions - November 11, 2009 Category: Drugs & Pharmacology Tags: Short communication Source Type: journals

HPV Vaccine Clears Viral Infection And May Reduce Cancerous LesionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. (Source: Cancer / Oncology News From Medical News Today)
Source: Cancer / Oncology News From Medical News Today - November 11, 2009 Category: Cancer & Oncology Tags: Cervical Cancer / HPV Vaccine Source Type: news

HPV Vaccine Clears Viral Infection And May Reduce Cancerous LesionsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A new vaccine designed to stimulate an immune response against a cancer-causing human papillomavirus (HPV-16) can eliminate chronic infection by the virus and may cause regression of precancerous genital lesions in women who receive the vaccine. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 11, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Circulating IL-1β levels, polymorphisms of IL-1B, and risk of cervical cancer in Chinese womenEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion  Functional IL-1B genotypes may modify plasma IL-1β concentrations to contribute to the etiology of cervical cancer in Chinese women; however, further perspective studies are warranted to test the causal effects of IL-1β concentration in cervical carcinogenesis. Content Type Journal ArticleCategory Original PaperDOI 10.1007/s00432-009-0710-5Authors Nianfeng Qian, Nanjing Medical University Laboratory of Reproductive Medicine 210029 Nanjing ChinaXiaojun Chen, Nanjing Medical University Laboratory of Reproductive Medicine 210029 Nanjing ChinaSuping Han, Nanjing Medical University Laboratory o...
Source: Journal of Cancer Research and Clinical Oncology - November 10, 2009 Category: Cancer & Oncology Tags: Journal of Cancer Research and Clinical Oncology Source Type: journals

Early tests on cervical cancer drugsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion This small study has shown that the oestrogen receptor blockers fulvestrant and raloxifene can treat cervical cancers in genetically engineered mice with this disease. Although these results suggest that the drugs may be worth investigating further for potential use in human cervical cancer, they may not represent the effects that the drugs would have in humans. As the researchers note, “Although our transgenic mouse model for HPV-associated cervical cancer recapitulates most aspects of human cervical cancer, it is obvious that further study is needed to determine whether this proposed model is relevant to h...
Source: NHS News Feed - November 10, 2009 Category: Consumer Health News Tags: Cancer Medical practice Source Type: news

Age-Specific Evaluation Of HPV DNA Testing Vs. Cytology ScreeningEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 10, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Age-Specific Evaluation Of HPV DNA Testing Vs. Cytology ScreeningEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online November 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. (Source: Genetics News From Medical News Today)
Source: Genetics News From Medical News Today - November 10, 2009 Category: Genetics & Stem Cells Tags: Cervical Cancer / HPV Vaccine Source Type: news

FDA Approves Cervical Cancer VaccineEmail this article to a colleague. Save this article to My Clippings. 1 CommentDiscuss or comment on this article.
The US Food and Drug Administration (FDA) has approved GlaxoSmithKline’s human papillomavirus bivalent (types 16 and 18) vaccine, recombinant (Cervarix) for the prevention of cervical precancers and cervical cancer associated with oncogenic human papillomavirus (HPV) types 16 and 18 for use in girls and young women (aged 10–25). Women are at risk of HPV infecti (Source: Cancer Network)
Source: Cancer Network - November 10, 2009 Category: Cancer & Oncology Source Type: info

FDA-Approved Drugs Eliminate, Prevent Cervical Cancer In MiceEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Researchers at the University of Wisconsin-Madison School of Medicine and Public Health have eliminated cervical cancer in mice with two FDA-approved drugs currently used to treat breast cancer and osteoporosis. Published in this week's (Nov. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 10, 2009 Category: Consumer Health News Tags: Cervical Cancer / HPV Vaccine Source Type: news

Persistence of Betapapillomavirus Infections as a Risk Factor for Actinic Keratoses, Precursor to Cutaneous Squamous Cell Carcinoma.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In conclusion, persistent betaPV infections in this population were associated with an increased occurrence of actinic keratosis. Additional studies are needed to determine the possible association of betaPV persistence with SCC. [Cancer Res 2009;69(23):OF1-6]. PMID: 19903846 [PubMed - as supplied by publisher] (Source: Cell Research)
Source: Cell Research - November 10, 2009 Category: Cytology Authors: Plasmeijer EI, Neale RE, de Koning MN, Quint WG, McBride P, Feltkamp MC, Green AC Tags: Cancer Res Source Type: journals

HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer.Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
CONCLUSIONS: HPV/p16-expression significantly improved outcome after radiotherapy in HNSCC. Hypoxic modification improved outcome in HPV/p16-negative tumours but was of no significant benefit in HPV/p16-positive tumours, suggesting that hypoxic radioresistance may not be clinically relevant in these tumours. PMID: 19910068 [PubMed - as supplied by publisher] (Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology)
Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - November 10, 2009 Category: Radiology Authors: Lassen P, Eriksen JG, Hamilton-Dutoit S, Tramm T, Alsner J, Overgaard J, Tags: Radiother Oncol Source Type: journals

Topical treatment of anogenital human papillomavirus infection in male patientsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Future Virology , November 2009, Vol. 4, No. 6, Pages 531-541. (Source: Future Virology)
Source: Future Virology - November 9, 2009 Category: Virology Tags: article Source Type: journals

The Prevalence of Human Papillomavirus Type 58 in Chinese Patients with Cervical Carcinoma and its Influence on SurvivalEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusion: No effect was seen of either treatment protocols or HPV type on survival, except for a slightly high survival in HPV 58 single-infected patients, which was statistically non-significant. (Source: Clinical Oncology)
Source: Clinical Oncology - November 9, 2009 Category: Radiology Authors: Walayat Shah, Chen Hongwei, Zheng Jin, Dong Lifang, Yu Jun, Wang Yili Tags: Original Article Source Type: journals

News brief: Age-specific evaluation of HPV DNA testing vs. cytology screeningEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
(Journal of the National Cancer Institute) Human papillomavirus (HPV) DNA testing with cytology triage is more sensitive than conventional cytology screening for detecting cervical lesions, according to a new study published online Nov. 9 in the Journal of the National Cancer Institute. Cytology triage in HPV-positive women can improve specificity. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 9, 2009 Category: Cancer & Oncology Source Type: news

Healthcare providers failing to provide HPV information to parentsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Survey results reveal that 85 percent of parents would like to receive information about the human papillomavirus from a healthcare provider, yet only 5 percent actually do. (Source: MedWire News - Ob/Gyn)
Source: MedWire News - Ob/Gyn - November 9, 2009 Category: OBGYN Source Type: news

Human papillomavirus testing with Pap triage for cervical cancer prevention in Canada: a cost-effectiveness analysisEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Conclusions: A strategy of human papillomavirus testing beginning at age 25, with Pap triage for women with positive human papillomavirus results may be more effective at reducing cervical cancer at a lower cost than the current recommended strategy for screening in Canada. (Source: BMC Medicine)
Source: BMC Medicine - November 9, 2009 Category: Internal Medicine Authors: Shalini KulasingamRaghu RajanYvan St.PierreC. Victoria AtwoodEvan MyersEduardo Franco Source Type: journals